Abstract
Kinase inhibitors are frequently used tools in signal transduction research. 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a potent inhibitor of glycogen synthase kinase 3β (GSK3β), is frequently used to activate β-catenin signaling by mimicking the action of Wnt molecules. β-Catenin is a crucial player in the regulation of hepatic drug metabolism. Thus, it is of particular importance to know whether the tools used to study the effects of β-catenin signaling may affect the respective drug-metabolizing target enzymes in an unwanted manner. In this study, we show that SB216763 is able to induce cytochrome P450 1a1 (Cyp1a1) expression in a dose-dependent manner in mouse hepatoma cells. Moreover, SB216763 is able to inhibit Cyp1a1 induction by the prototype aryl hydrocarbon receptor (AhR) ligand 2,3,7,8-tetrachloro-p-dibenzodioxin. Cyp1a1 induction by SB216763 is independent of GSK3β and the β-catenin pathway. Instead, SB216763 induces Cyp1a1 by activation of AhR-mediated transcription. The present results suggest that SB216763 acts as a partial agonist of the AhR.
Footnotes
-
This work was supported by the Deutsche Forschungsgemeinschaft [Grant SFB 773].
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.109.027821.
-
ABBREVIATIONS: AhR, aryl hydrocarbon receptor; Arnt, AhR nuclear translocator; DRE, dioxin response element; U0126, 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophynyltio)butadiene; PD98059, 2′-amino-3′-methoxyflavone; SP600125, 1,9-pyrazoloanthrone; GSK3β, glycogen synthase kinase 3β; SB216763, 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; TCF, T cell factor; P450, cytochrome P450; TCDD, 2,3,7,8-tetrachloro-p-dibenzodioxin; PCR, polymerase chain reaction; RT, reverse transcription.
- Accepted May 15, 2009.
- Received April 3, 2009.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|